Gvh-496.mp4 -

: Advanced research is exploring VHH-CAR T cells (nanobody-based chimeric antigen receptor T cells). These are designed to target specific antigens like MET in solid tumors while minimizing the "tonic signaling" that often leads to T-cell exhaustion.

: For patients with GvHD-related complications, treatments such as Eculizumab are being used to inhibit the C5 complement pathway, though this requires careful monitoring for infections like Neisseria meningitidis . Technical Context (Digital Files) gvh-496.mp4

However, the naming convention is frequently associated with medical and biological research concerning Graft-versus-Host Disease (GvHD) , a condition common after hematopoietic stem cell transplantations. : Advanced research is exploring VHH-CAR T cells